4.8 Article

Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex

期刊

ONCOGENE
卷 33, 期 41, 页码 4916-4923

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2013.430

关键词

c-Myc; TRBP2; microRNA; RPL11; RPL5; ribosomal stress

资金

  1. National Institutes of Health (NIH)-National Cancer Institute (NCI) [CA095441, CA079721, CA129828, CA172468]

向作者/读者索取更多资源

Oncogene MYC is highly expressed in many human cancers and functions as a global regulator of ribosome biogenesis. Previously, we reported that ribosomal protein (RP) L11 binds to c-Myc and inhibits its transcriptional activity in response to ribosomal stress. Here, we show that RPL5, co-operatively with RPL11, guides the RNA-induced silencing complex (RISC) to c-Myc mRNA and mediates the degradation of the mRNA, consequently leading to inhibition of c-Myc activity. Knocking down of RPL5 induced c-Myc expression at both mRNA and protein levels, whereas overexpression of RPL5 suppressed c-Myc expression and activity. Immunoprecipitation revealed that RPL5 binds to 3'UTR of c-Myc mRNA and two subunits of RISC, TRBP (HIV-1 TAR RNA-binding protein) and Ago2, mediating the targeting of c-Myc mRNA by miRNAs. Interestingly, RPL5 and RPL11 co-resided on c-Myc mRNA and suppressed c-Myc expression co-operatively. These findings uncover a mechanism by which these two RPs can co-operatively suppress c-Myc expression, allowing a tightly controlled ribosome biogenesis in cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

p53 induces ARTS to promote mitochondrial apoptosis

Qian Hao, Jiaxiang Chen, Junming Liao, Yingdan Huang, Yu Gan, Sarit Larisch, Shelya X. Zeng, Hua Lu, Xiang Zhou

Summary: ARTS and p53 collaborate closely in mitochondria-engaged apoptosis, with ARTS inducing apoptosis by antagonizing anti-apoptotic proteins and p53 activating the expression of ARTS.

CELL DEATH & DISEASE (2021)

Article Genetics & Heredity

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer

Shanshan Wang, Xuan Zou, Yajie Chen, William C. Cho, Xiang Zhou

Summary: The study revealed that m^6A methylation regulators were significantly dysregulated in TNBC tissues, and could serve as a novel prognostic signature for predicting the survival of TNBC patients.

FRONTIERS IN GENETICS (2021)

Article Biochemistry & Molecular Biology

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

Fei Xu, Jiajia Li, Mengdong Ni, Jingyi Cheng, Haiyun Zhao, Shanshan Wang, Xiang Zhou, Xiaohua Wu

Summary: The study revealed that FBW7 suppresses tumor growth and progression in ovarian cancer by antagonizing YTHDF2-mediated BMF mRNA decay. This highlights the importance of the FBW7-YTHDF2 regulatory axis in ovarian cancer development and suggests potential therapeutic targets for the treatment of this disease.

MOLECULAR CANCER (2021)

Article Oncology

Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth

Jieqiong Wang, Yajie Chen, Canhua Huang, Qian Hao, Shelya X. Zeng, Sara Omari, Yu Zhang, Xiang Zhou, Hua Lu

Summary: Valosin-containing protein (VCP) has been identified as a novel regulator of p53-R273H stability, stabilizing p53-R273H through binding to MDM2 and disrupting its association with mutant p53, while inhibition of VCP leads to ubiquitination and degradation of p53-R273H, promoting cell death. VCP may serve as a potential target for the development of pancreatic cancer therapy.

CANCER RESEARCH (2021)

Editorial Material Oncology

The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy

Qian Hao, Xiang Zhou

CANCER BIOLOGY & MEDICINE (2022)

Article Oncology

Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress

Tao Han, Jing Tong, Mengxin Wang, Yu Gan, Bo Gao, Jiaxiang Chen, Youxun Liu, Qian Hao, Xiang Zhou

Summary: Olaparib is a widely used PARP inhibitor in the treatment of solid tumors. Its anti-tumor activity is achieved through the inhibition of PARP enzymes and blocking DNA repair. This study reveals that Olaparib activates the nucleolar stress-RPs-p53 pathway, leading to the activation of p53 and the inhibition of cancer cell survival and proliferation.

FRONTIERS IN ONCOLOGY (2022)

Review Pharmacology & Pharmacy

The discovery and development of RNA-based therapies for treatment of HIV-1 infection

Michelle J. Chen, Anne Gatignol, Robert J. Scarborough

Summary: This review examines the development of RNA technologies for treating HIV-1 infections over the past three decades, assessing their efficacy and safety. RNA-based therapies have the potential to be long-term and effective treatments for inhibiting HIV-1 through gene therapy.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Editorial Material Cell Biology

Editorial: The expanding network of p53 signaling: Reaching to the unknown of cancer

Xiang Zhou, Ji Hoon Jung, Hua Lu

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Cell Biology

The ARTS of p53-dependent mitochondrial apoptosis

Qian Hao, Jiaxiang Chen, Hua Lu, Xiang Zhou

Summary: The tumor-suppressive activity of p53 is mainly due to its ability to induce cell death, specifically apoptosis, through various mechanisms. It transcriptionally activates pro-apoptotic genes and inhibits anti-apoptotic genes, leading to mitochondrial apoptosis. It also promotes mitochondrial apoptosis by directly interacting with BCL-2 family proteins in the mitochondria. ARTS, a pro-apoptotic protein encoded by an alternative spliced variant of the SEPT4 gene, facilitates BCL-2 and XIAP degradation, triggering apoptosis. ARTS is a new p53 target gene that enhances mitochondrial apoptosis by interacting with p53. This review discusses the mechanisms of p53-induced mitochondrial apoptosis, the role of ARTS in regulating mitochondrial cell death, and the clinical significance of ARTS in cancer and non-cancer diseases.

JOURNAL OF MOLECULAR CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Cuproptosis: p53-regulated metabolic cell death?

Chen Xiong, Hong Ling, Qian Hao, Xiang Zhou

Summary: Cuproptosis is a newly identified form of copper-induced cell death that primarily affects cells relying on oxidative phosphorylation as their main energy source. This process involves copper binding to lipoylated proteins in the tricarboxylic acid cycle, leading to the aggregation of these proteins, destabilization of iron-sulfur cluster proteins, and proteotoxic stress. Cancer cells, on the other hand, predominantly utilize glycolysis and are resistant to cuproptosis. However, the tumor suppressor p53, which regulates metabolism, may have a role in cuproptosis regulation by influencing glycolysis and the biogenesis of iron-sulfur clusters and the copper chelator glutathione.

CELL DEATH AND DIFFERENTIATION (2023)

Review Cell Biology

Regulation of the tumor immune microenvironment by cancer-derived circular RNAs

Liping Guan, Qian Hao, Fenfen Shi, Bo Gao, Mengxin Wang, Xiang Zhou, Tao Han, Wenjie Ren

Summary: Circular RNA (circRNAs) is a circular non-coding RNA formed by back-splicing from precursor messenger RNA. It can be released and captured by other cell types, acting as connections between different cell types for signaling pathways. CircRNAs reshape the tumor microenvironment (TME) by regulating epithelial-stromal transformation, tumor vascularization, immune cell function, and inflammatory responses, playing a crucial role in cancer development.

CELL DEATH & DISEASE (2023)

Article Biochemistry & Molecular Biology

UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis

Yu Gan, Jun Deng, Qian Hao, Yingdan Huang, Tao Han, Jin-Guo Xu, Min Zhao, Litong Yao, Yingying Xu, Jianping Xiong, Hua Lu, Chunmeng Wang, Jiaxiang Chen, Xiang Zhou

Summary: In this study, it was found that UTP11 plays a crucial role in the biosynthesis of 18S ribosomal RNAs (rRNA) by binding to the pre-rRNA processing factor, MPP10. UTP11 is overexpressed in human cancers and is associated with poor prognoses. Depletion of UTP11 inhibits cancer cell growth through p53-dependent and -independent mechanisms, while UTP11 overexpression promotes cancer cell growth and progression. The study also reveals that UTP11 depletion triggers nucleolar stress and enhances ferroptosis, contributing to the inhibition of cancer cell survival and growth.

REDOX BIOLOGY (2023)

Article Biochemistry & Molecular Biology

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer

Litong Yao, Qian Hao, Mozhi Wang, Yuhai Chen, Hongyi Cao, Qiang Zhang, Keda Yu, Yizhou Jiang, Zhiming Shao, Xiang Zhou, Yingying Xu

Summary: In this study, researchers identified KLHL29 as a crucial tumor suppressor that regulates chemosensitivity in triple-negative breast cancer (TNBC). Low levels of KLHL29 were associated with unfavorable prognoses. Mechanistically, KLHL29 suppressed TNBC growth by degrading DDX3X and inhibiting cell cycle progression. The combination of DDX3X inhibitor RK33 and platinum-based chemotherapy showed promising results in suppressing TNBC.

ONCOGENE (2023)

Letter Biology

Nucleolar stress promotes and cooperates with ferroptosis to suppress cancer growth

Hanzhi Dong, Quan Liao, Bangxiang Xie, Yu-an Qiu, Zhiqiang Peng, Jun Deng, Jianping Xiong, Hua Lu, Qian Hao, Xiang Zhou

SCIENCE CHINA-LIFE SCIENCES (2023)

Article Medicine, General & Internal

Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma

Bangxiang Xie, Qian Hao, Xiang Zhou, Dexi Chen

Summary: The HBx protein of hepatitis B virus interacts with the TAp63 protein and inhibits its transcriptional activity, leading to the progression of hepatocellular carcinoma with defective p53.

CHINESE MEDICAL JOURNAL (2022)

暂无数据